Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stromal Protein-Mediated Immune Regulation in Digestive Cancers
Pia Gamradt, Christelle de la Fouchardière, Anà Hennino
Cancers (2021) Vol. 13, Iss. 1, pp. 146-146
Open Access | Times Cited: 22

Showing 22 citing articles:

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Peijie Wu, Wei Gao, Miao Su, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 159
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications
Karim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3805-3805
Open Access | Times Cited: 132
Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer
Songwei Feng, Yi Xu, Zhu Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 78
Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
Hang Zheng, Heshu Liu, Huayu Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 58
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications
Peijie Wu, Jun Han, Yanju Gong, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 1990-1990
Open Access | Times Cited: 43
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Xiangyi Kong, Xintong Xie, Juan Wu, et al.
Cancer Communications (2025)
Open Access
Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer
Zizheng Wu, Yuan-Jun Wei, Tong Li, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 4, pp. 700-720
Open Access | Times Cited: 3
Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses
Yan Wang, Zhengbo Chen, Gang Zhao, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-18
Open Access | Times Cited: 8
SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients
Cristina Galindo-Pumariño, Manuel Collado, María E. Castillo, et al.
Toxicology and Applied Pharmacology (2022) Vol. 450, pp. 116171-116171
Open Access | Times Cited: 14
Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
Jiawei Dong, Fang Wang, Xin Gao, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 7
Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics
Lei Gu, Dan Ding, Cuicui Wei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Bioinformatic analysis of N6-methyladenosine, 5-methylcytosine, and N1-methyladenosine co-regulation patterns and validation of NSUN6 as a protective protein in colon cancer
Wenjie Xie, Zhao Sun, Yang Fu
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
Sofia Parrasia, Mario Zoratti, Ildikò Szabó, et al.
Cellular Physiology and Biochemistry (2020) Vol. 55, Iss. 1, pp. 61-90
Open Access | Times Cited: 8
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner
Pia Gamradt, Kevin Thierry, M. Masmoudi, et al.
PNAS Nexus (2023) Vol. 2, Iss. 12
Open Access | Times Cited: 2
Glucose oxidase virus‐based nanoreactors for smart breast cancer therapy
Pedro Gama, Patricia Juárez, Ana G. Rodríguez‐Hernández, et al.
Biotechnology Journal (2023) Vol. 18, Iss. 10
Open Access | Times Cited: 2
Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database
Danlei Song, Yongjian Wei, Yuping Hu, et al.
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Perfusion for hyperthermic intraperitoneal chemotherapy by cardiopulmonary bypass machine
Mustafa Duman, Erdal Polat, Mehmet Fatih Can, et al.
Elsevier eBooks (2023), pp. 515-526
Closed Access | Times Cited: 1
Hydrogel‐Based Strategies to Enhance T‐Cell Performance for Solid Tumor Immunotherapy
Seung Won Oh, Pilnam Kim
Advanced Therapeutics (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 1
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 623-623
Open Access | Times Cited: 2
Differential expression of COL6 family is a potential tumor marker for predicting gastric cancer
Lei Ma, Yanfeng Wang, Tao Li, et al.
Research Square (Research Square) (2023)
Open Access
Glucose oxidase virus-based nanoreactors for smart breast cancer therapy
Pedro Gama, Patrcica Juarez, Ana G. Rodríguez‐Hernández, et al.
Authorea (Authorea) (2023)
Open Access
NSUN6 as a Key RNA Methylation Regulator in Colon Cancer
Qian Zhao, Zhao Sun, Hongyi Li, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top